Trial Outcomes & Findings for eSET Plus Single Embryo Cryotransfer vs Double Embryo Transfer (NCT NCT01909570)

NCT ID: NCT01909570

Last Updated: 2024-05-16

Results Overview

A clinical pregnancy was defined by the presence of a gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

194 participants

Primary outcome timeframe

Seven weeks after embryo transfer

Results posted on

2024-05-16

Participant Flow

The recruitment period was from January 2010 to December 2012. The location of the recruitment was University Hospital of Virgen de las Nieves in Granada.

A total of 194 women aged under 38 years were included in the study. Of these, 19 women were not randomised. The reasons were refusion to participate (n= 6), economic reasons (n = 2), participating in another study (n= 7) and not meeting criteria in further evaluation (n = 4).

Participant milestones

Participant milestones
Measure
Elective Single Embryo Transfer
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
Double Embryo Transfer
Transfer of two fresh embryos
Overall Study
STARTED
84
91
Overall Study
COMPLETED
57
64
Overall Study
NOT COMPLETED
27
27

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

eSET Plus Single Embryo Cryotransfer vs Double Embryo Transfer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Elective Single Embryo Transfer
n=84 Participants
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
Double Embryo Transfer
n=91 Participants
Transfer of two fresh embryos
Total
n=175 Participants
Total of all reporting groups
Age, Continuous
32.2 years
STANDARD_DEVIATION 3.6 • n=5 Participants
31.7 years
STANDARD_DEVIATION 3.8 • n=7 Participants
32.0 years
STANDARD_DEVIATION 3.7 • n=5 Participants
Sex: Female, Male
Female
84 Participants
n=5 Participants
91 Participants
n=7 Participants
175 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
84 Participants
n=5 Participants
91 Participants
n=7 Participants
175 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
Spain
84 participants
n=5 Participants
91 participants
n=7 Participants
175 participants
n=5 Participants

PRIMARY outcome

Timeframe: Seven weeks after embryo transfer

Population: Women aged under 38 years, with BMI between 19-29 kg/m2, FSH \<15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.

A clinical pregnancy was defined by the presence of a gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Outcome measures

Outcome measures
Measure
Elective Single Embryo Transfer
n=84 Participants
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
Double Embryo Transfer
n=91 Participants
Transfer of two fresh embryos
Clinical Pregnancy Rate
44.0 percentage of pregnancy per transfer
37.4 percentage of pregnancy per transfer

SECONDARY outcome

Timeframe: Seven weeks after embryo transfer

Population: Women aged under 38 years, with BMI between 19-29 kg/m2, FSH \<15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.

A multiple clinical pregnancy was defined by the presence of more than one gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy

Outcome measures

Outcome measures
Measure
Elective Single Embryo Transfer
n=84 Participants
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
Double Embryo Transfer
n=91 Participants
Transfer of two fresh embryos
Multiple Pregnancy Rate
0 percentage of multiple pregnancies
26.4 percentage of multiple pregnancies

OTHER_PRE_SPECIFIED outcome

Timeframe: 38 weeks after embryo transfer

Population: Women aged under 38 years, with BMI between 19-29 kg/m2, FSH \<15mUI/mL on the third day and first cycle of IVF/ICSI or second cycle after a prior attempt with a positive pregnancy test result. The infertile period must be less of five years, without previous uterine surgery, uterine malformations, neither repeated spontaneous abortions.

The delivery of a healthy child (o two)

Outcome measures

Outcome measures
Measure
Elective Single Embryo Transfer
n=84 Participants
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
Double Embryo Transfer
n=91 Participants
Transfer of two fresh embryos
Live Birth Delivery Rate
45.2 percentage of live birth
41.8 percentage of live birth

Adverse Events

Elective Single Embryo Transfer

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Double Embryo Transfer

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Elective Single Embryo Transfer
n=84 participants at risk
Elective single embryo transfer plus single embryo cryotransfer in case of no fresh conception
Double Embryo Transfer
n=91 participants at risk
Transfer of two fresh embryos
Pregnancy, puerperium and perinatal conditions
premature birth
3.6%
3/84 • Number of events 3
3.3%
3/91 • Number of events 3
Reproductive system and breast disorders
Hiperstimulation Ovarian Syndrome
0.00%
0/84
2.2%
2/91 • Number of events 2

Additional Information

Dr. Ana Clavero

University Hospital Virgen de las Nieves

Phone: 0034958020482

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place